Ibogaine Research Guide

Full name: Ibogaine (from Tabernanthe iboga)

A plant-derived psychedelic studied mainly for interrupting opioid and other substance addictions. A single session is reported to sharply reduce withdrawal and cravings, but it carries real heart-rhythm risks that demand medical monitoring.

How Ibogaine Works

Acts on multiple systems at once, including serotonin and opioid receptors, NMDA receptors and nicotinic receptors. Its active metabolite noribogaine is thought to drive much of the lasting anti-addiction effect.

Dosing Protocol

• Typical dose: Weight-based, given in specialized clinics
• Frequency: Usually a single session
• Duration: Acute effects last 8-24 hours
• Route: Oral, under medical and cardiac monitoring

Reported Benefits

• Studied for opioid use disorder
• Can reduce withdrawal symptoms quickly
• May lower cravings after a single session
• Investigated for traumatic brain injury (with magnesium) in veterans

Potential Side Effects

• Dangerous heart-rhythm changes (QT prolongation)
• Ataxia (loss of coordination)
• Nausea and vomiting
• Long, intense experience
• Risk of death without cardiac monitoring

Research Citations

1. Magnesium-Ibogaine therapy in veterans with traumatic brain injury (2024) - Stanford study reported large reductions in PTSD, anxiety and depression and improved functioning after a single supervised treatment.
2. Ibogaine for opioid detoxification (observational) (2018) - Reported reductions in opioid withdrawal and craving, while emphasizing cardiac safety concerns.

Related Psychedelics Compounds

• MDMA - Full Profile
• Psilocybin - Full Profile
• LSD - Full Profile
• DMT - Full Profile
• Ayahuasca - Full Profile
• 5-MeO-DMT - Full Profile

View full Ibogaine profile with 3D molecule viewer →